Molnupiravir 200 mg

Molnupiravir 200 mg Capsule is an FDA-authorized oral antiviral medicine developed for the treatment of mild to moderate COVID-19 in adults who are at high risk of progression to severe disease, including hospitalization or death.

Molnupiravir works by introducing errors into the viral RNA during replication, which prevents the coronavirus (SARS-CoV-2) from multiplying effectively in the body. By reducing viral load, it helps minimize symptoms and lowers the risk of complications.

Medical Uses of Molnupiravir 200 mg:

• Treatment of mild to moderate COVID-19 in adults

• For patients at high risk due to comorbidities (diabetes, heart disease, obesity, etc.)

• To reduce risk of hospitalization and severe outcomes

Key Benefits:

• Convenient oral capsule – no injections needed

• Effective in reducing viral replication

• Helps prevent severe COVID-19 progression

• Can be taken at home under medical supervision

How to Use:
The recommended dose is 800 mg (four 200 mg capsules) taken every 12 hours for 5 days. Treatment should be started as soon as possible after a confirmed COVID-19 diagnosis and within 5 days of symptom onset.

Possible Side Effects:
Headache, nausea, dizziness, diarrhea, and mild fatigue. Serious side effects are rare, but Molnupiravir is not recommended during pregnancy due to potential risks.